180 related articles for article (PubMed ID: 22749137)
1. Lactobacillus casei Shirota protects from fructose-induced liver steatosis: a mouse model.
Wagnerberger S; Spruss A; Kanuri G; Stahl C; Schröder M; Vetter W; Bischoff SC; Bergheim I
J Nutr Biochem; 2013 Mar; 24(3):531-8. PubMed ID: 22749137
[TBL] [Abstract][Full Text] [Related]
2. Metformin protects against the development of fructose-induced steatosis in mice: role of the intestinal barrier function.
Spruss A; Kanuri G; Stahl C; Bischoff SC; Bergheim I
Lab Invest; 2012 Jul; 92(7):1020-32. PubMed ID: 22525431
[TBL] [Abstract][Full Text] [Related]
3. Toll-like receptors 1-9 are elevated in livers with fructose-induced hepatic steatosis.
Wagnerberger S; Spruss A; Kanuri G; Volynets V; Stahl C; Bischoff SC; Bergheim I
Br J Nutr; 2012 Jun; 107(12):1727-38. PubMed ID: 22018861
[TBL] [Abstract][Full Text] [Related]
4. Toll-like receptor 4 is involved in the development of fructose-induced hepatic steatosis in mice.
Spruss A; Kanuri G; Wagnerberger S; Haub S; Bischoff SC; Bergheim I
Hepatology; 2009 Oct; 50(4):1094-104. PubMed ID: 19637282
[TBL] [Abstract][Full Text] [Related]
5. Lactobacillus rhamnosus GG protects against non-alcoholic fatty liver disease in mice.
Ritze Y; Bárdos G; Claus A; Ehrmann V; Bergheim I; Schwiertz A; Bischoff SC
PLoS One; 2014; 9(1):e80169. PubMed ID: 24475018
[TBL] [Abstract][Full Text] [Related]
6. Short-Term Intake of a Fructose-, Fat- and Cholesterol-Rich Diet Causes Hepatic Steatosis in Mice: Effect of Antibiotic Treatment.
Brandt A; Jin CJ; Nolte K; Sellmann C; Engstler AJ; Bergheim I
Nutrients; 2017 Sep; 9(9):. PubMed ID: 28906444
[TBL] [Abstract][Full Text] [Related]
7. Lactobacillus casei strain Shirota protects against nonalcoholic steatohepatitis development in a rodent model.
Okubo H; Sakoda H; Kushiyama A; Fujishiro M; Nakatsu Y; Fukushima T; Matsunaga Y; Kamata H; Asahara T; Yoshida Y; Chonan O; Iwashita M; Nishimura F; Asano T
Am J Physiol Gastrointest Liver Physiol; 2013 Dec; 305(12):G911-8. PubMed ID: 24113768
[TBL] [Abstract][Full Text] [Related]
8. Diets rich in fructose, fat or fructose and fat alter intestinal barrier function and lead to the development of nonalcoholic fatty liver disease over time.
Sellmann C; Priebs J; Landmann M; Degen C; Engstler AJ; Jin CJ; Gärttner S; Spruss A; Huber O; Bergheim I
J Nutr Biochem; 2015 Nov; 26(11):1183-92. PubMed ID: 26168700
[TBL] [Abstract][Full Text] [Related]
9. Fructose-induced steatosis in mice: role of plasminogen activator inhibitor-1, microsomal triglyceride transfer protein and NKT cells.
Kanuri G; Spruss A; Wagnerberger S; Bischoff SC; Bergheim I
Lab Invest; 2011 Jun; 91(6):885-95. PubMed ID: 21423135
[TBL] [Abstract][Full Text] [Related]
10. Rosiglitazone and bezafibrate modulate gene expression in a rat model of non-alcoholic fatty liver disease--a historical prospective.
Schmilovitz-Weiss H; Hochhauser E; Cohen M; Chepurko Y; Yitzhaki S; Grossman E; Leibowitz A; Ackerman Z; Ben-Ari Z
Lipids Health Dis; 2013 Mar; 12():41. PubMed ID: 23531105
[TBL] [Abstract][Full Text] [Related]
11. Role of the inducible nitric oxide synthase in the onset of fructose-induced steatosis in mice.
Spruss A; Kanuri G; Uebel K; Bischoff SC; Bergheim I
Antioxid Redox Signal; 2011 Jun; 14(11):2121-35. PubMed ID: 21083420
[TBL] [Abstract][Full Text] [Related]
12. Probiotic Lactobacillus casei Zhang ameliorates high-fructose-induced impaired glucose tolerance in hyperinsulinemia rats.
Zhang Y; Wang L; Zhang J; Li Y; He Q; Li H; Guo X; Guo J; Zhang H
Eur J Nutr; 2014 Feb; 53(1):221-32. PubMed ID: 23797890
[TBL] [Abstract][Full Text] [Related]
13. Metformin attenuates the onset of non-alcoholic fatty liver disease and affects intestinal microbiota and barrier in small intestine.
Brandt A; Hernández-Arriaga A; Kehm R; Sánchez V; Jin CJ; Nier A; Baumann A; Camarinha-Silva A; Bergheim I
Sci Rep; 2019 Apr; 9(1):6668. PubMed ID: 31040374
[TBL] [Abstract][Full Text] [Related]
14. Oral citrulline supplementation protects female mice from the development of non-alcoholic fatty liver disease (NAFLD).
Sellmann C; Jin CJ; Engstler AJ; De Bandt JP; Bergheim I
Eur J Nutr; 2017 Dec; 56(8):2519-2527. PubMed ID: 27496089
[TBL] [Abstract][Full Text] [Related]
15. Protective effect of bile acids on the onset of fructose-induced hepatic steatosis in mice.
Volynets V; Spruss A; Kanuri G; Wagnerberger S; Bischoff SC; Bergheim I
J Lipid Res; 2010 Dec; 51(12):3414-24. PubMed ID: 20847296
[TBL] [Abstract][Full Text] [Related]
16. Effects of a Lactobacillus paracasei B21060 based synbiotic on steatosis, insulin signaling and toll-like receptor expression in rats fed a high-fat diet.
Raso GM; Simeoli R; Iacono A; Santoro A; Amero P; Paciello O; Russo R; D'Agostino G; Di Costanzo M; Canani RB; Calignano A; Meli R
J Nutr Biochem; 2014 Jan; 25(1):81-90. PubMed ID: 24314869
[TBL] [Abstract][Full Text] [Related]
17. Effect of specific amino acids on hepatic lipid metabolism in fructose-induced non-alcoholic fatty liver disease.
Jegatheesan P; Beutheu S; Ventura G; Sarfati G; Nubret E; Kapel N; Waligora-Dupriet AJ; Bergheim I; Cynober L; De-Bandt JP
Clin Nutr; 2016 Feb; 35(1):175-182. PubMed ID: 25736031
[TBL] [Abstract][Full Text] [Related]
18. Citrulline decreases hepatic endotoxin-induced injury in fructose-induced non-alcoholic liver disease: an ex vivo study in the isolated perfused rat liver.
Ouelaa W; Jegatheesan P; M'bouyou-Boungou J; Vicente C; Nakib S; Nubret E; De Bandt JP
Br J Nutr; 2017 Jun; 117(11):1487-1494. PubMed ID: 28637520
[TBL] [Abstract][Full Text] [Related]
19. Supplementation of sodium butyrate protects mice from the development of non-alcoholic steatohepatitis (NASH).
Jin CJ; Sellmann C; Engstler AJ; Ziegenhardt D; Bergheim I
Br J Nutr; 2015 Dec; 114(11):1745-55. PubMed ID: 26450277
[TBL] [Abstract][Full Text] [Related]
20. Female mice are more susceptible to nonalcoholic fatty liver disease: sex-specific regulation of the hepatic AMP-activated protein kinase-plasminogen activator inhibitor 1 cascade, but not the hepatic endotoxin response.
Spruss A; Henkel J; Kanuri G; Blank D; Püschel GP; Bischoff SC; Bergheim I
Mol Med; 2012 Dec; 18(1):1346-55. PubMed ID: 22952059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
